Global healthcare giant GSK PLC (NYSE: GSK) has received a BUY recommendation from Argus Research, with analysts projecting a 14% total return potential through June 2026.

Market analyst Varun Dubey has suggested four BUY Calls for today’s trading session. Indian markets are expected to open strong today and we can witness stock specific action in the markets.